Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer (Q36804537)
Jump to navigation
Jump to search
scientific article published on 10 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer |
scientific article published on 10 April 2013 |
Statements
1 reference
Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer (English)
1 reference
Martin H Cohen
1 reference
Huanyu Chen
1 reference
Stacy Shord
1 reference
Chana Fuchs
1 reference
Kun He
1 reference
Hong Zhao
1 reference
Sharon Sickafuse
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
10 April 2013
1 reference
1 reference
460-466
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference